IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

New Leaf Venture Partners, L.L.C.

Q4 2016 Holdings

Filed 2017-02-14 | 15 holdings | $139.6K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Versartis IncCOM92529L102$30.4K2,039,22321.8%
Edge Therapeutics IncCOM279870109$29.3K2,344,86821.0%
Oxford Immunotec Global PLCORD SHSG6855A103$20.6K1,377,49714.8%
Wave Life Sciences LTD(WVE)SHSY95308105$17.2K658,25912.3%
Crispr Therapeutics AG(CRSP)NAMEN AKTH17182108$11.9K586,4758.5%
Dimension Therapeutics IncCOM25433V105$9.0K2,059,2836.4%
Sage Therapeutics Inc(SG7)COM78667J108$5.8K114,1234.2%
Dermira Inc(DERMEUR)COM24983L104$5.4K177,8443.9%
Alder Biopharmaceuticals Inc(ALDR1EUR)COM014339105$4.8K228,4283.4%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$1.4K2,590,6731.0%
Vistagen Therapeutics Inc(VTGNUSD)COM92840H202$1.3K352,9500.9%
Dynavax Technologies Corp(DVAX)COM268158201$1.0K256,3810.7%
Lombard Medical IncCOMG55598109$6431,072,6340.5%
Trillium Therapeutics IncCOM89620X506$54796,7590.4%
Inotek Pharmaceuticals CorpCOM45780V102$38062,3000.3%